Letter
Nature 446, 685-689 (5 April 2007) | doi:10.1038/nature05673; Received 12 December 2006; Accepted 9 February 2007; Published online 21 March 2007
Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1
Masahiro Ono1,2,6, Hiroko Yaguchi3,6, Naganari Ohkura3,6, Issay Kitabayashi4, Yuko Nagamura3, Takashi Nomura1, Yoshiki Miyachi2, Toshihiko Tsukada3 & Shimon Sakaguchi1,5
- Department of Experimental Pathology, Institute for Frontier Medical Sciences, and
- Department of Dermatology, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan
- Tumor Endocrinology Project, and,
- Molecular Oncology Division, National Cancer Center Research Institute, Chuo-ku, Tokyo, 104-0045, Japan
- Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency, Kawaguchi 332-0012, Japan
- These authors contributed equally to this work.
Correspondence to: Shimon Sakaguchi1,5 Correspondence and requests for materials should be addressed to S.S. (Email: shimon@frontier.kyoto-u.ac.jp).
Naturally arising CD25+CD4+ regulatory T cells (TR cells) are engaged in the maintenance of immunological self-tolerance and immune homeostasis by suppressing aberrant or excessive immune responses, such as autoimmune disease and allergy1, 2, 3. TR cells specifically express the transcription factor Foxp3, a key regulator of TR-cell development and function. Ectopic expression of Foxp3 in conventional T cells is indeed sufficient to confer suppressive activity, repress the production of cytokines such as interleukin-2 (IL-2) and interferon-gamma (IFN-
), and upregulate TR-cell-associated molecules such as CD25, cytotoxic T-lymphocyte-associated antigen-4, and glucocorticoid-induced TNF-receptor-family-related protein4, 5, 6, 7. However, the method by which Foxp3 controls these molecular events has yet to be explained. Here we show that the transcription factor AML1 (acute myeloid leukaemia 1)/Runx1 (Runt-related transcription factor 1), which is crucially required for normal haematopoiesis including thymic T-cell development8, 9, 10, 11, activates IL-2 and IFN-
gene expression in conventional CD4+ T cells through binding to their respective promoters. In natural TR cells, Foxp3 interacts physically with AML1. Several lines of evidence support a model in which the interaction suppresses IL-2 and IFN-
production, upregulates TR-cell-associated molecules, and exerts suppressive activity. This transcriptional control of TR-cell function by an interaction between Foxp3 and AML1 can be exploited to control physiological and pathological T-cell-mediated immune responses.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Cdk6 blocks myeloid differentiation by interfering with Runx1 DNA binding and Runx1-C/EBPα interactionThe EMBO Journal Article
Cdk6 blocks myeloid differentiation by interfering with Runx1 DNA binding and Runx1-C/EBPα interactionThe EMBO Journal Article (02 May 2007)
Requirement for O-linked N-acetylglucosaminyltransferase in lymphocytes activationThe EMBO Journal Article
Requirement for O-linked N-acetylglucosaminyltransferase in lymphocytes activationThe EMBO Journal Article (17 Oct 2007)
CD69 acts downstream of interferon-α/β to inhibit S1P 1 and lymphocyte egress from lymphoid organsNature Letters to Editor (23 Mar 2006)
See all 6 matches for Research